{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:27:17Z","timestamp":1791286037070,"version":"4.1.0"},"reference-count":29,"publisher":"EDP Sciences","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1051\/medsci\/20062211985","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T12:06:28Z","timestamp":1299326788000},"page":"985-989","source":"Crossref","is-referenced-by-count":8,"title":["Mutations des prot\u00e9ines de la coagulation et thromboses"],"prefix":"10.1051","volume":"22","author":[{"given":"Martine","family":"Aiach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Alhenc-Gelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Borgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Emmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gandrille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2006,11,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"De Lange M, Snieder H, Ariens RA,et al.The genetics of haemostasis: a twin study.Lancet2001; 357 : 101\u20135.","DOI":"10.1016\/S0140-6736(00)03541-8"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Ariens RA, de Lange M, Snieder H,et al.Activation markers of coagulation and fibrinolysis in twins : heritability of the prethrombotic state.Lancet2002; 359 : 667\u201371.","DOI":"10.1016\/S0140-6736(02)07813-3"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Souto JC, Almasy L, Borrell M,et al.Genetic determinants of hemostasis phenotypes in Spanish families.Circulation2000; 101 : 1546\u201351.","DOI":"10.1161\/01.CIR.101.13.1546"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Egeberg O. Inherited antithrombin deficiency causing thrombophilia.Thromb Diath Haemorr1965; 13 : 516\u201330.","DOI":"10.1055\/s-0038-1656297"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Lane DA, Bayston T, Olds RJ,et al.Antithrombin mutation database : 2nd(1997) update. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the International society on thrombosis and haemostasis.Thromb Haemost1997; 77 : 197\u2013211.","DOI":"10.1055\/s-0038-1655930"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Kuhle S, Lane DA, Jochmanns K,et al.Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.Thromb Haemost2001; 86 : 1007\u201311.","DOI":"10.1055\/s-0037-1616525"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Picard V, Dautzenberg MD, Villoutreix BO,et al.Antithrombin Phe229Leu : a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis.Blood2003; 102 : 919\u201325.","DOI":"10.1182\/blood-2002-11-3391"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Griffin JH, Evatt B, Zimmerman TS,et al.Deficiency of protein C in congenital thrombotic disease.J Clin Invest1981; 68 : 1370\u20133.","DOI":"10.1172\/JCI110385"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Reitsma PH, Bernardi F, Doig RG,et al.Protein C deficiency : a database of mutations, 1995 update. On behalf of the subcommittee on plasma coagulation inhibitors of the scientific and standardization committee of the ISTH.Thromb Haemost1995; 73 : 876\u201389.","DOI":"10.1055\/s-0038-1653885"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Gandrille S, Aiach M. Identification of mutations in 90 of 121 consecutive symptomatic French patients with a type I protein C deficiency. The French Inserm network on molecular abnormalities responsible for protein C and protein S deficiencies.Blood1995; 86 : 2598\u2013605.","DOI":"10.1182\/blood.V86.7.2598.bloodjournal8672598"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis.J Clin Invest1984; 74 : 2082\u20138.","DOI":"10.1172\/JCI111632"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Gandrille S, Borgel D, Ireland H,et al.Protein S deficiency : a database of mutations. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the International society on thrombosis and haemostasis.Thromb Haemost1997; 77 : 1201\u201314.","DOI":"10.1055\/s-0038-1656138"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis.N Engl J Med2001; 344 : 1222\u201331.","DOI":"10.1056\/NEJM200104193441607"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C : prediction of a cofactor to activated protein C.Proc Natl Acad Sci USA1993; 90 : 1004\u20138.","DOI":"10.1073\/pnas.90.3.1004"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3\u2019-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.Blood1996; 88 : 3698\u2013703.","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Bernardi F, Faioni EM, Castoldi E,et al.A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype.Blood1997; 90 : 1552\u20137.","DOI":"10.1182\/blood.V90.4.1552.1552_1552_1557"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Emmerich J, Rosendaal FR, Cattaneo M,et al.Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study group for pooled-analysis in venous thromboembolism.Thromb Haemost2001; 86 : 809\u201316.","DOI":"10.1055\/s-0037-1616136"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Ridker PM, Hennekens CH, Lindpaintner K,et al.Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.N Engl J Med1995; 332 : 912\u20137.","DOI":"10.1056\/NEJM199504063321403"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Martinelli I, Mannucci PM, De Stefano V,et al.Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia : a study of 150 families.Blood1998; 92 : 2353\u20138.","DOI":"10.1182\/blood.V92.7.2353"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance).Blood1995; 85 : 1504\u20138.","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Bounameaux H. Factor V Leiden paradox : risk of deep-vein thrombosis but not of pulmonary embolism.Lancet2000; 356 : 182\u20133.","DOI":"10.1016\/S0140-6736(00)02476-4"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Koeleman BP, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.Blood1994; 84 : 1031\u20135.","DOI":"10.1182\/blood.V84.4.1031.bloodjournal8441031"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Gandrille S, Greengard JS, Alhenc-Gelas M,et al.Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French network on the behalf of Inserm.Blood1995; 86 : 219\u201324.","DOI":"10.1182\/blood.V86.1.219.bloodjournal861219"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Van Boven HH, Vandenbroucke JP, Briet E, Rosendaal FR. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency.Blood1999; 94 : 2590\u20134.","DOI":"10.1182\/blood.V94.8.2590.420k40_2590_2594"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Borgel D, Duchemin J, Alhenc-Gelas M,et al.Molecular basis for protein S hereditary deficiency : genetic defects observed in 118 patients with type I and type IIa deficiencies. The French network on molecular abnormalities responsible for protein C and protein S deficiencies.J Lab Clin Med1996; 128 : 218\u201327.","DOI":"10.1016\/S0022-2143(96)90015-3"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Alhenc-Gelas M, Reny JL, Aubry ML,et al.The FXIII Val 34 Leu mutation and the risk of venous thrombosis.Thromb Haemost2000; 84 : 1117\u20138.","DOI":"10.1055\/s-0037-1614180"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Saposnik B, Reny JL, Gaussem P,et al.A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis.Blood2004; 103 : 1311\u20138.","DOI":"10.1182\/blood-2003-07-2520"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects.Arch Intern Med2000; 160 : 49\u201352.","DOI":"10.1001\/archinte.160.1.49"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Schreijer AJM, Cannegieter SC, Meijers JCM,et al.Activation of coagulation system during air travel : a crossover study.Lancet2006; 367 : 832\u20138.","DOI":"10.1016\/S0140-6736(06)68339-6"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20062211985\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T02:27:55Z","timestamp":1592360875000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20062211985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":29,"journal-issue":{"issue":"11"},"alternative-id":["medsci20062211p985"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/20062211985","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}